close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Smith & Nephew SNATS, Inc. Common Stock (NY:SNN)

29.31 -0.88 (-2.91%)
Official Closing Price Updated: 4:10 PM EDT, Aug 19, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Smith & Nephew SNATS, Inc. Common Stock

< Previous 1 2 3 Next >
News headline image
Smith & Nephew SNATS Q2 Earnings Call Highlights ↗
Smith & Nephew SNATS (NYSE:SNN) reported second-quarter underlying revenue growth of 1.6%, below management’s expectations, as continued strength in Sports Medicine and ENT was offset by weakness in... 
Via MarketBeat
Topics Earnings World Trade
News headline image
Smith & Nephew (SNN) Q2 2026 Earnings Call Transcript ↗
Nath addresses Orthopaedics gaps and skin substitute headwinds. 
Via The Motley Fool
Topics Earnings Economy World Trade
Smith & Nephew plc (NYSE:SNN) Caviar Cruise Screen Analysis ↗
Via Chartmill
Smith & Nephew (NYSE:SNN) Qualifies as a Quality Investment Through the Caviar Cruise Screen ↗
Via Chartmill
Smith & Nephew PLC (NYSE:SNN) Passes the Caviar Cruise Screen for Quality Investing ↗
Via Chartmill
News headline image
Earnings Scheduled For February 25, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For August 3, 2023 ↗
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million. 
Via Benzinga
News headline image
Smith & Nephew PLC (NYSE:SNN): A Value Investment in Medical Devices ↗
Smith & Nephew (SNN) is a value investment in medical devices, with strong profitability, accelerating growth, and attractive valuation metrics. 
Via Chartmill
News headline image
Organogenesis Holdings (ORGO) Battles Headwinds: Can This Regenerative Medicine Innovator Stage a Comeback?
Canton, MA – Organogenesis Holdings Inc. (NASDAQ: ORGO), a prominent player in the regenerative medicine sector, has recently endured a period of significant stock weakness, leaving investors... 
Via MarketMinute
Topics Fraud
News headline image
Trump Administration Review Targets Medical Supply Chain Vulnerabilities ↗
The U.S. Commerce Department, under the Trump administration, has launched a national security review of medical imports—including PPE, consumables, and medical devices—to assess reliance on foreign... 
Via Benzinga
Topics Economy Government Supply Chain
News headline image
What Does the Market Think About Smith & Nephew? ↗
 
Via Benzinga
News headline image
Sterling Infrastructure Posts Better-Than-Expected Earnings, Joins Lemonade, DigitalOcean Holdings, Lattice Semiconductor And Other Big Stocks Moving Higher On Tuesday ↗
 
Via Benzinga
News headline image
Top 2 Health Care Stocks You May Want To Dump In Q3 ↗
 
Via Benzinga
News headline image
Why Palantir Technologies Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
This PepsiCo Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday ↗
 
Via Benzinga
News headline image
Xpeng, Li Auto And Nutanix Are Among Top 12 Large-Cap Gainers Last Week (Feb 24-Feb 28): Are The Others In Your Portfolio? ↗
These large-cap stocks were top performers last week. Heico, Xpeng, Li Auto, Lineage, Erie Indemnity, Lloyds, Unum, FICO, Masimo, Smith & Nephew, AB InBev, and Nutanix all saw significant gains. 
Via Benzinga
News headline image
Estée Lauder, Robinhood, eBay And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why NIO Shares Are Trading Lower By Over 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
Shares of NIO Inc. (NYSE:NIO) fell sharply during Friday's session after the company disclosed that Steven Wei Feng has resigned as the Chief Financial Officer for personal and family 
Via Benzinga
News headline image
Macy's, Koss And Other Big Stocks Moving Higher On Friday ↗
 
Via Benzinga
News headline image
Activist Investor Takes Stake In Sports Medicine Player Smith & Nephew, Shares Surge ↗
Smith & Nephew shares rise as Cevian Capital acquires a 5% stake, aiming to improve operational performance. The medical tech firm faces challenges with declining market cap and mixed revenue growth. 
Via Benzinga
News headline image
4 Stocks to Watch in the Booming Regenerative Medicine Market
4 Stocks to Watch in the Booming Regenerative Medicine Market 
Via News Direct
News headline image
Current Analysis: Smith & Nephew ↗
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Over the past year, SNN's share price fell about 9.4% from... 
Via Talk Markets
News headline image
7 Robotic Surgery Stocks to Buy for the Future of Healthcare ↗
Discover seven robotic surgery stocks primed for growth as the industry evolves. Unveil opportunities in a market set to double by 2033. 
Via InvestorPlace
News headline image
British MedTech Firm Smith & Nephew Seeks To Adopt US-Inspired Pay Policy to Navigate Shareholder Skepticism ↗
Smith & Nephew shakes up executive pay structure, aligning with US standards to curb turnover. Chairman Rupert Soames addresses global talent recruitment challenges and the shift's significance in the... 
Via Benzinga
News headline image
3 Millionaire-Maker Robotics Stocks to Buy in February 2024 ↗
Jump into the future with top robotics stocks poised for explosive growth. Discover the potential for massive returns. 
Via InvestorPlace
News headline image
Alphabet To Rally Over 10%? Here Are 10 Other Analyst Forecasts For Wednesday ↗
Citigroup raised the price target for LyondellBasell Industries N.V. (NYSE: LYB) from $104 to $106. Citigroup analyst Patrick Cunningham upgraded the stock from Neutral to Buy. LyondellBasell... 
Via Benzinga
News headline image
Smith & Nephew Raises Revenue Growth Outlook After Strong 1H Performance, Sports Medicine and Wound Management Show Strength ↗
Smith & Nephew PLC (NYSE: SNN) reported improved revenue, profit, and margin in the  
Via Benzinga
News headline image
AstraZeneca, ECARX Holdings And Other Big Stocks Moving Lower On Monday ↗
U.S. stocks traded mixed, with the Dow Jones dropping around 30 points on Monday. Here are some big stocks recording losses in today’s session. Protagonist Therapeutics, Inc. (NASDAQ: PTGX) shares... 
Via Benzinga
News headline image
Amgen Out, Rio Tinto In As Morgan Stanley Shuffles Dividend Deck ↗
 
Via Benzinga
News headline image
Boeing, CyberArk Lead 5 Stocks Near Buy Points ↗
The market rally is going strong, but watch out for a potential pullback. 
Via Investor's Business Daily
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.